Initial Prior Authorization Terbinafine Tablets
Customize your policy alerts
Sign up for cvs_caremark Policy 364-A alerts
Get alerted when Policy 364-A changes without checking for updates manually.
Monitor payer policy activity
This policy governs initial prior authorization coverage for generic terbinafine tablets used to treat onychomycosis, tinea capitis, tinea corporis, and tinea cruris.
No material clinical or coverage changes in this revision.
Coverage Criteria
Onychomycosis
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.